Avalo Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVTX and other ETFs, options, and stocks.

About AVTX

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. 

CEO
Garry Arthur Neil
CEOGarry Arthur Neil
Employees
19
Employees19
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2011
Founded2011
Employees
19
Employees19

AVTX Key Statistics

Market cap
14.85M
Market cap14.85M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
—
Dividend yield—
Average volume
76.36K
Average volume76.36K
High today
$16.00
High today$16.00
Low today
$13.15
Low today$13.15
Open price
$15.58
Open price$15.58
Volume
91.53K
Volume91.53K
52 Week high
$1,130.40
52 Week high$1,130.40
52 Week low
$3.95
52 Week low$3.95
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.